Evaluation of the toxicity of 2-aminoimidazole antibiofilm agents using both cellular and model organism systems

Drug and Chemical Toxicology

Volumn 35, Issue 3, 2012, Pages 310-315

  Stowe, Sean D ^a   Tucker, Ashley T ^a   Thompson, Richele ^a   Piper, Amanda ^a   Richards, Justin J ^a   Rogers, Steven A ^a   Mathies, Laura D ^a   Melander, Christian ^a   Cavanagh, John ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

2 aminoimidazole; adjuvant; biofilm; Caenorhabditis elegans; toxicity; Toxicity of 2 aminoimidazole antibiofilm agents

Indexed keywords

2 AMINOIMIDAZOLE ANTIBIOFILM AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; DIHYDROSVENTRIN; UNCLASSIFIED DRUG;

ARTICLE; BIOFILM; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; IC 50; KERATINOCYTE; NONHUMAN;

ADJUVANTS, PHARMACEUTIC; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CAENORHABDITIS ELEGANS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; FERTILITY; HUMANS; IMIDAZOLES; KERATINOCYTES; TETRAZOLIUM SALTS; THIAZOLES; TOXICITY TESTS;

BACTERIA (MICROORGANISMS); CAENORHABDITIS ELEGANS;

EID: 84862884193     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.3109/01480545.2011.614620     Document Type: Article

References (40)

1. Artal-Sanz, M., de Jong, L., Tavernarakis, N. (2006). Caenorhabditis elegans: a versatile platform for drug discovery. Biotechnol J 1:1405-1418.
2. Ballard, T. E., Richards, J. J., Wolfe, A. L., Melander, C. (2008). Synthesis and antibiofilm activity of a second-generation reverse-amide oroidin library: a structure-activity relationship study. Chem Eur J 14:10745-10761.
3. Bickmeyer, U. (2005). Bromoageliferin and dibromoageliferin, secondary metabolites from the marine sponge Agelas conifera, inhibit voltage-operated, but not store-operated calcium entry in PC12 cells. Toxicon 45:627-632.
4. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771. (Pubitemid 18089976)
5. Boyd, W. A., McBride, S. J., Rice, J. R., Snyder, D. W., Freedman, J. H. (2010). A high-throughput method for assessing chemical toxicity using a Caenorhabditis elegans reproduction assay. Toxicol Appl Pharmacol 245:153-159.
6. Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77:71-94.
7. Burns, A. R., Kwok, T. C. Y., Howard, A., Houston, E., Johanson, K., Chan, A., et al. (2006). High-throughput screening of small molecules for bioactivity and target identification in Caenorhabditis elegans. Nat Protocols 1:1906-1914. (Pubitemid 46773310)
8. Costerton, J. W., Stewart, P. S., Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322. (Pubitemid 29289651)
9. Costerton, W., Veeh, R., Shirtliff, M., Pasmore, M., Post, C., Ehrlich, G. (2003). The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest 112:1466-1477. (Pubitemid 38056271)
10. Davies, D. (2003). Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov 2:114-122.
11. Denizot, F., Lang, R. (1986). Rapid colorimetric assay for cell growth and survival: modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277. (Pubitemid 16080782)
12. Donlan, R. M., Costerton, J. W. (2002). Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193. (Pubitemid 34303762)
13. George, S. E., Anderson, R. J., Cunningham, A., Donaldson, M., Groundwater, P. W. (2010). Evaluation of a range of anti-proliferative assays for the preclinical screening of anti-psoriatic drugs: a comparison of colorimetric and fluorimetric assays with the thymidine incorporation assay. Assay Drug Dev Technol 8:384-395.
14. Hirsch, T., Koerber, A., Jacobsen, F., Dissemond, J., Steinau, H.-U., Gatermann, S., et al. (2009). Evaluation of toxic side effects of clinically used skin antiseptics in vitro. J Surg Res 164:344-350.
15. Hope, I. A. (Ed.). (1999). C. elegans: a practical approach. New York: Oxford University Press.
16. Huigens, R. W., III, Ma, L., Gambino, C., Moeller, P. D. R., Basso, A., Cavanagh, J., et al. (2008). Control of bacterial biofilms with marine alkaloid derivatives. Mol BioSyst 4:614-621. (Pubitemid 351706305)
17. Huigens, R. W., Richards, J. J., Parise, G., Ballard, T. E., Zeng, W., Deora, R., et al. (2007). Inhibition of Pseudomonas aeruginosa biofilm formation with bromoageliferin analogues. J Am Chem Soc 129:6966-6967. (Pubitemid 46903240)
18. Kaletta, T., Hengartner, M. O. (2006). Finding function in novel targets: C. elegans as a model organism. Nat Rev Drug Discov 5:387-399. (Pubitemid 43904931)
19. Kwok, T. C. Y., Ricker, N., Fraser, R., Chan, A. W., Burns, A., Stanley, E. F., et al. (2006). A small-molecule screen in C. elegans yields a new calcium channel antagonist. Nature 441:91-95.
20. Leung, M. C. K., Williams, P. L., Benedetto, A., Au, C., Helmcke, K. J., Aschner, M., et al. (2008). Caenorhabditis elegans: an emerging model in biomedical and environmental toxicology. Toxicol Sci 106:5-28.
21. Lewis, J. A., Fleming, J. T. (1995). Basic culture methods. In: Epstein, H., Shakes, D. (Eds.), Methods in cell biology (pp. 3-29). San Diego, California, USA: Academic.
22. Lynch, A. S., Abbanat, D. (2010). New antibiotic agents and approaches to treat biofilm-associated infections. Expert Opin Ther Pat 20:1373-1387.
23. Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
24. Mukai, D., Matsuda, N., Yoshioka, Y., Sato, M., Yamasaki, T. (2008). Potential anthelmintics: polyphenols from the tea plant Camellia sinensis L. are lethally toxic to Caenorhabditis elegans. J Nat Med 62:155-159.
25. Musk, D. J., Jr., and Hergenrother, P. J. (2006). Chemical countermeasures for the control of bacterial biofilms: effective compounds and promising targets. Curr Med Chem 13:2163-2177.
26. National Research Council. (2000). Scientific frontiers in developmental toxicology and risk assessment.Washington, DC: National Academy Press.
27. Omura, S., Crump, A. (2004). The life and times of ivermectin-a success story. Nat Rev Micro 2:984-989. (Pubitemid 39562537)
28. Pace, J. L., Rupp, M. E., Finch, R. G. (Eds.). (2006). Biofilms, infection, and antimicrobial therapy. Boca Raton, Florida, USA: CRC.
29. Parsek, M. R., Singh, P. K. (2003). Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57:677-701. (Pubitemid 37392958)
30. Ponec, M. (1992). In vitro cultured human skin cells as alternatives to animals for skin irritancy screening. Int J Cosmet Sci 14:245-264.
31. Richards, J. J., Ballard, T. E., Huigens, R. W., Melander, C. (2008a). Synthesis and screening of an oroidin library against Pseudomonas aeruginosa biofilms. ChemBioChem 9:1267-1279.
32. Richards, J. J., Huigens, R. W., III, Ballard, T. E., Basso, A., Cavanagh, J., Melander, C. (2008b). Inhibition and dispersion of proteobacterial biofilms. Chem Commun 1698-1700. (Pubitemid 351441911)
33. Richards, J. J., Reyes, S., Stowe, S. D., Tucker, A. T., Ballard, T. E., Mathies, L. D., et al. (2009). Amide isosteres of oroidin: assessment of antibiofilm activity and C. elegans toxicity. J Med Chem 52:4582-4585.
34. Riddle, D. L., Blumenthal, T., Meyer, B. J., Priess, J. R. (Eds.). (1997). C. elegans II. Cold Spring Harbor, New York, USA: Cold Spring Harbor Laboratory Press.
35. Rogers, S. A., Huigens, R. W., III, Cavanagh, J., Melander, C. (2010). Synergistic effects between conventional antibiotics and 2-aminoimidazole- derived antibiofilm agents. Antimicrob Agents Chemother 54:2112-2118.
36. Rogers, S. A., Melander, C. (2008). Construction and screening of a 2-aminoimidazole library identifies a small molecule capable of inhibiting and dispersing bacterial biofilms across order, class, and phylum. Angew Chem Int Ed 47:5229-5231.
37. Stoodley, P., Sauer, K., Davies, D. G., Costerton, J. W. (2002). Biofilms as complex differentiated communities. Annu Rev Microbiol 56:187-209. (Pubitemid 35217453)
38. Wilhelm, K. P., Böttjer, B., Siegers, C. P. (2001). Quantitative assessment of primary skin irritants in vitro in a cytotoxicity model: comparison with in vivo human irritation tests. Br J Dermatol 145:709-715. (Pubitemid 33078340)
39. Wilhelm, K. P., Samblebe, M., Siegers, C. P. (1994). Quantitative in vitro assessment of N-alkyl sulphate-induced cytotoxicity in human keratinocytes (HaCaT). Comparison with in vivo human irritation tests. Br J Dermatol 130:18-23.
40. Wood, W. B. (Ed.). (1988). The nematode Caenorhabditis elegans. Cold Spring Harbor, New York, USA: Cold Spring Harbor Laboratory Press.